Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNI
about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotectionReducing myocardial infarct size: challenges and future opportunitiesCardioprotection by remote ischemic conditioning: Mechanisms and clinical evidencesCardiac MR imaging: current status and future direction.Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryChest Pain of Suspected Cardiac Origin: Current Evidence-based Recommendations for Prehospital CareCardioprotection: Where to from here?Neutrophil stunning by metoprolol reduces infarct sizeQuantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance.Novel adjunctive treatments of myocardial infarction.Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatmentRemote ischemic conditioning.The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigsImpact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study.Cardiovascular remodelling in coronary artery disease and heart failure.Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?Recent advances in the diagnosis and treatment of acute myocardial infarctionCTGF/CCN2 Postconditioning Increases Tolerance of Murine Hearts towards Ischemia-Reperfusion Injury.Potential economic consequences of a cardioprotective agent for patients with myocardial infarction: modelling study.Effect of early bisoprolol administration on ventricular arrhythmia and cardiac death in patients with non-ST elevation myocardial infarctionDesign and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial InfaAstragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats.Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance.Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future.Remote conditioning the heart overview: translatability and mechanism.Prognostic implications of arrhythmias during primary percutaneous coronary interventions for ST-elevation myocardial infraction.Ischaemic conditioning: are we there yet?Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to be Learnt by Translating Results from Animal Models to the Clinical Settings.Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial.Magnetic resonance imaging for characterizing myocardial diseases.The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.Pacing Postconditioning: Recent Insights of Mechanism of Action and Probable Future Clinical ApplicationPredictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction.Protective approaches against myocardial ischemia reperfusion injuryEMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention.
P2860
Q24289195-53BBEB62-3B40-46DE-AAB2-3C0A866C9183Q26750797-4EDB309A-92E8-499D-A398-07EE14921445Q26775395-87F70FEB-500D-4392-989A-C75FD6AD6ED7Q26777868-41D56035-8A39-43E2-8766-D288FCE3D4FFQ26786658-2CB5FCE5-D9D5-4FD8-8E6A-B679CB1A1449Q28072918-782FEBE1-98F7-4CCD-A38E-5F20077ADA76Q28073736-E14BFB31-58F1-4D8A-92D5-956CEE028E2BQ30244797-A5B9B94A-FDF3-4FA9-8D07-7C2218CF16C2Q33587119-1CB8A3E7-4EA0-449D-B333-9CD45B5546AAQ33720141-96B10297-05DB-4527-A66A-7DD173859960Q33812924-AFB3DD30-7899-425A-8231-83616A9EE2C2Q33827278-4513CC42-C1BF-4776-8CDD-4A59740D7FF0Q34458416-AB97DCCB-DEFD-4B30-BE19-53A6F2349671Q35085312-3D3D130E-32F5-4A41-BA5D-B0479639912AQ35088064-0A49D1AC-4787-450E-837C-055CDF6C9E0CQ35090566-1F5D0718-79ED-47D9-925C-A37311A7BF55Q35286339-CAA9CF61-615B-4C95-9686-E8AEFDBE5927Q35626702-1E3565EE-230C-4C78-A216-6742FAAE6C9DQ35922588-1694F75E-AA63-471E-A469-6DED66F717FAQ36302787-DBE03779-1BFB-4522-875C-064CCC616AEAQ36801124-CF8C1055-451C-44BE-B8D3-920F892DADCDQ37177523-EB91A5F3-0968-4023-BAB6-DB3F660B105CQ37448086-2BF69C71-9D6D-4471-A0AA-46CA4EF5EDD6Q37521985-63F0C408-B7C7-40C2-A5E5-A53887815493Q37738596-403AC714-3497-4454-8B26-4C3BFCE068DAQ38199493-4A72283C-6929-44B8-8D72-FF7A6CBE8D93Q38247701-EE16BC70-0DA8-4D5F-A8B6-105232B8AF1EQ38249023-7B50D200-9A93-4A1F-BFA5-DFC55D3E0CDEQ38283800-8B175405-26C2-465F-B69E-F3953AE29DB4Q38427068-9816E118-22AB-4597-9237-863AF28C849AQ38541215-5D9CF1CC-5DC2-4997-A467-0BBE142C3627Q38542449-A7B4A32E-B995-4E61-9409-7CB9B914093AQ38573070-45E8B2AA-9F11-4761-93AB-95B1D9C05A55Q38614650-4EE4832F-38E6-4CEC-A9CD-A1D6ADB69CA8Q38736889-FF7A4491-D4B2-4721-A717-8861C5103505Q38880162-AAC9D944-717B-4569-B734-C59F8BAAFEC9Q39007673-BF13584E-954E-460E-B4F1-4D2E35FD7D63Q40061457-290FA6F0-AC79-46F0-BB76-32B2E37F4199Q41381059-8EAB65D6-8500-4913-B740-F67CC72058DAQ45022516-185FE96A-C4C0-43DF-871C-318D4B47DBCA
P2860
Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNI
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of early metoprolol on ...... rdial Infarction (METOCARD-CNI
@en
type
label
Effect of early metoprolol on ...... rdial Infarction (METOCARD-CNI
@en
prefLabel
Effect of early metoprolol on ...... rdial Infarction (METOCARD-CNI
@en
P2093
P50
P1433
P1476
Effect of early metoprolol on ...... rdial Infarction (METOCARD-CNI
@en
P2093
Agustín Albarrán
Alonso Mateos
Ana García-Álvarez
Andrés Iñiguez
Borja Ruiz-Mateos
Carlos Acebal
Carlos Cuellas
Carlos Macaya
Felipe Fernández-Vázquez
Ginés Sanz
P304
P356
10.1161/CIRCULATIONAHA.113.003653
P407
P50
P577
2013-09-03T00:00:00Z